Corcept Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
Corcept Therapeutics(CORT) stock is priced at $78.90, giving the company a market capitalization of 8.34B. It carries a P/E multiple of 91.18.
On 2025-11-29, Corcept Therapeutics(CORT) stock moved within a range of $78.63 to $84.50. With shares now at $78.90, the stock is trading +0.3% above its intraday low and -6.6% below the session's peak.
Trading volume for Corcept Therapeutics(CORT) stock has reached 201.5K, versus its average volume of 512.82K.
The stock's 52-week range extends from a low of $49.00 to a high of $117.33.
The stock's 52-week range extends from a low of $49.00 to a high of $117.33.
CORT News
Corcept Therapeutics (CORT) has adjusted its revenue outlook for 2025, citing capacity constraints with a previous specialty pharmacy vendor. This adjustment co...
Image source: The Motley Fool. Tuesday, Nov. 4, 2025 at 7:26 p.m. ET Call participants Chief Executive Officer — Joseph K. Belanoff Chief Business Officer — Ga...
Analyst Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Corcept Therapeutics and keeping the price target at $145.00. TipRanks Black Frid...
More CORT News
Wondering if Corcept Therapeutics is really worth its recent buzz, or if the market might be missing something about this fast-growing biotech? You are not alon...